In our earlier study we demonstrated co-regulation of

inflammatory with anti-inflammatory CD4+ T cells in CL disease [10]. In order to understand more clearly the possible role of the specific Vβ CD4+ T cell subpopulations in CL disease, correlation analyses were performed between the frequency of proinflammatory (IFN-γ and TNF-α) and anti-inflammatory (IL-10) cytokine-producing cells for each of the specific Vβ CD4+ T cell subpopulations following stimulation with SLA. Among the three Vβ families that demonstrated higher frequencies of TNF-α-, IFN-γ- and IL-10-producing cells, two of them, GSK2126458 datasheet Vβ 5·2 and 24, demonstrated strong positive correlations between the frequency of cells producing IL-10 and TNF-α or IFN-γ (Vβ 5·2) (Fig. 7). In addition, the Vβ 8 subpopulation (P = 0·02, data not shown) demonstrated

a positive correlation. Our earlier data demonstrated a direct correlation between the frequency of both activated T cells and IFN-γ-producing lymphocytes and the size of ulcerated cutaneous lesions in CL disease [15]. Thus, it was of great interest to verify if any of the specific CD4+ Vβ subpopulations also correlated with lesion size as a method of identifying possible T cell subpopulations involved with the local immune response and possible tissue damage. Interestingly, correlation analyses revealed a positive correlation between higher frequencies of Vβ 5·2 CD4+ T cells and larger lesion areas (Fig. 8). Thus, three Vβ subpopulations (Vβ 5·2, 11 and 24) were identified as having a significant and consistent RG-7388 clinical trial bias towards involvement with the anti-Leishmania response as measured by a variety of indicators, such as overall frequency, portion of cells committed to an ‘experienced’ phenotype and cytokine production.

One of these, Vβ 5·2, also showed a positive correlation with lesion size. Given that there is intense trafficking of lymphocytes from the local draining lymph nodes through the blood and to lesions, we have seen that the blood often reflects what is happening at lesion sites in CL and mucosal disease when considering the overall immunoregulatory profile [10,12,13,34]. However, specific T cell Dynein subpopulations could be expected to accumulate in lesions if they express receptors specific for a prevalent antigen. This preferential accumulation would be identified by a higher percentage of cells expressing a given TCR Vβ segment in the inflammatory infiltrate compared to the percentage of these same TCR Vβ-expressing cells in the blood. Given the positive correlation of CD4+ Vβ 5·2-expressing T cells with lesion size and their greater frequency of activation and cytokine production as measured by all criteria examined in this study, we analysed the percentage of these cells among CD4+ T cells in the inflammatory infiltrate of lesions from a group of CL patients.